Logo image of COHR

COHERENT CORP (COHR) Stock Fundamental Analysis

USA - NYSE:COHR - US19247G1076 - Common Stock

109.11 USD
+1.06 (+0.98%)
Last: 9/19/2025, 8:04:00 PM
109.12 USD
+0.01 (+0.01%)
After Hours: 9/19/2025, 8:04:00 PM
Fundamental Rating

4

COHR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 125 industry peers in the Electronic Equipment, Instruments & Components industry. There are concerns on the financial health of COHR while its profitability can be described as average. COHR is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

COHR had positive earnings in the past year.
In the past year COHR had a positive cash flow from operations.
In multiple years COHR reported negative net income over the last 5 years.
COHR had a positive operating cash flow in each of the past 5 years.
COHR Yearly Net Income VS EBIT VS OCF VS FCFCOHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M

1.2 Ratios

With a Return On Assets value of -0.54%, COHR perfoms like the industry average, outperforming 49.60% of the companies in the same industry.
COHR has a Return On Equity (-0.99%) which is in line with its industry peers.
COHR has a Return On Invested Capital (3.62%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for COHR is significantly below the industry average of 9.48%.
The 3 year average ROIC (1.91%) for COHR is below the current ROIC(3.62%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.54%
ROE -0.99%
ROIC 3.62%
ROA(3y)-1.8%
ROA(5y)0.14%
ROE(3y)-3.42%
ROE(5y)-0.03%
ROIC(3y)1.91%
ROIC(5y)3.38%
COHR Yearly ROA, ROE, ROICCOHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10

1.3 Margins

The Operating Margin of COHR (10.34%) is better than 76.80% of its industry peers.
COHR's Operating Margin has improved in the last couple of years.
COHR has a Gross Margin (35.17%) which is in line with its industry peers.
COHR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.34%
PM (TTM) N/A
GM 35.17%
OM growth 3Y-9.74%
OM growth 5Y23.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y0.42%
COHR Yearly Profit, Operating, Gross MarginsCOHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), COHR is destroying value.
COHR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, COHR has more shares outstanding
Compared to 1 year ago, COHR has an improved debt to assets ratio.
COHR Yearly Shares OutstandingCOHR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
COHR Yearly Total Debt VS Total AssetsCOHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

COHR has a debt to FCF ratio of 19.13. This is a negative value and a sign of low solvency as COHR would need 19.13 years to pay back of all of its debts.
COHR's Debt to FCF ratio of 19.13 is in line compared to the rest of the industry. COHR outperforms 52.80% of its industry peers.
A Debt/Equity ratio of 0.43 indicates that COHR is not too dependend on debt financing.
COHR has a worse Debt to Equity ratio (0.43) than 62.40% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 19.13
Altman-Z N/A
ROIC/WACC0.39
WACC9.36%
COHR Yearly LT Debt VS Equity VS FCFCOHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

COHR has a Current Ratio of 2.19. This indicates that COHR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of COHR (2.19) is comparable to the rest of the industry.
A Quick Ratio of 1.39 indicates that COHR should not have too much problems paying its short term obligations.
COHR has a Quick ratio of 1.39. This is in the lower half of the industry: COHR underperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 1.39
COHR Yearly Current Assets VS Current LiabilitesCOHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

7

3. Growth

3.1 Past

COHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.87%, which is quite impressive.
The Earnings Per Share has been growing slightly by 6.89% on average over the past years.
COHR shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.42%.
COHR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.54% yearly.
EPS 1Y (TTM)116.87%
EPS 3Y-1.09%
EPS 5Y6.89%
EPS Q2Q%63.93%
Revenue 1Y (TTM)23.42%
Revenue growth 3Y20.55%
Revenue growth 5Y19.54%
Sales Q2Q%16.39%

3.2 Future

COHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.30% yearly.
COHR is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.90% yearly.
EPS Next Y29.83%
EPS Next 2Y23.21%
EPS Next 3Y27.3%
EPS Next 5YN/A
Revenue Next Year8.74%
Revenue Next 2Y7.94%
Revenue Next 3Y9.9%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COHR Yearly Revenue VS EstimatesCOHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
COHR Yearly EPS VS EstimatesCOHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.31, the valuation of COHR can be described as expensive.
COHR's Price/Earnings ratio is a bit cheaper when compared to the industry. COHR is cheaper than 64.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.38. COHR is around the same levels.
The Price/Forward Earnings ratio is 23.35, which indicates a rather expensive current valuation of COHR.
Based on the Price/Forward Earnings ratio, COHR is valued a bit cheaper than the industry average as 64.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of COHR to the average of the S&P500 Index (22.86), we can say COHR is valued inline with the index average.
Industry RankSector Rank
PE 30.31
Fwd PE 23.35
COHR Price Earnings VS Forward Price EarningsCOHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

69.60% of the companies in the same industry are more expensive than COHR, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as COHR.
Industry RankSector Rank
P/FCF 88.19
EV/EBITDA 16.99
COHR Per share dataCOHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

COHR's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
COHR's earnings are expected to grow with 27.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.02
PEG (5Y)4.4
EPS Next 2Y23.21%
EPS Next 3Y27.3%

0

5. Dividend

5.1 Amount

No dividends for COHR!.
Industry RankSector Rank
Dividend Yield N/A

COHERENT CORP

NYSE:COHR (9/19/2025, 8:04:00 PM)

After market: 109.12 +0.01 (+0.01%)

109.11

+1.06 (+0.98%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners94.79%
Inst Owner Change1.29%
Ins Owners0.6%
Ins Owner Change3.74%
Market Cap17.00B
Analysts81.38
Price Target114.74 (5.16%)
Short Float %5.27%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.07
Dividend Growth(5Y)N/A
DP-14.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.73%
Min EPS beat(2)4.19%
Max EPS beat(2)7.27%
EPS beat(4)4
Avg EPS beat(4)15.98%
Min EPS beat(4)4.19%
Max EPS beat(4)34.28%
EPS beat(8)8
Avg EPS beat(8)19.38%
EPS beat(12)11
Avg EPS beat(12)12.81%
EPS beat(16)15
Avg EPS beat(16)10.72%
Revenue beat(2)1
Avg Revenue beat(2)0.67%
Min Revenue beat(2)-0.56%
Max Revenue beat(2)1.9%
Revenue beat(4)3
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-0.56%
Max Revenue beat(4)2.33%
Revenue beat(8)5
Avg Revenue beat(8)0.5%
Revenue beat(12)6
Avg Revenue beat(12)-0.56%
Revenue beat(16)8
Avg Revenue beat(16)-0.71%
PT rev (1m)8.03%
PT rev (3m)16.94%
EPS NQ rev (1m)2.39%
EPS NQ rev (3m)4.36%
EPS NY rev (1m)1.71%
EPS NY rev (3m)4.01%
Revenue NQ rev (1m)-0.25%
Revenue NQ rev (3m)1.43%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 30.31
Fwd PE 23.35
P/S 2.93
P/FCF 88.19
P/OCF 26.83
P/B 2.09
P/tB 37.61
EV/EBITDA 16.99
EPS(TTM)3.6
EY3.3%
EPS(NY)4.67
Fwd EY4.28%
FCF(TTM)1.24
FCFY1.13%
OCF(TTM)4.07
OCFY3.73%
SpS37.29
BVpS52.16
TBVpS2.9
PEG (NY)1.02
PEG (5Y)4.4
Profitability
Industry RankSector Rank
ROA -0.54%
ROE -0.99%
ROCE 4.58%
ROIC 3.62%
ROICexc 3.89%
ROICexgc 10.47%
OM 10.34%
PM (TTM) N/A
GM 35.17%
FCFM 3.32%
ROA(3y)-1.8%
ROA(5y)0.14%
ROE(3y)-3.42%
ROE(5y)-0.03%
ROIC(3y)1.91%
ROIC(5y)3.38%
ROICexc(3y)2.05%
ROICexc(5y)4.61%
ROICexgc(3y)5.86%
ROICexgc(5y)10.02%
ROCE(3y)2.42%
ROCE(5y)4.28%
ROICexcg growth 3Y-16.13%
ROICexcg growth 5Y26.18%
ROICexc growth 3Y-25.01%
ROICexc growth 5Y18.65%
OM growth 3Y-9.74%
OM growth 5Y23.86%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y0.42%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 19.13
Debt/EBITDA 3.03
Cap/Depr 79.63%
Cap/Sales 7.59%
Interest Coverage 2.34
Cash Conversion 54.9%
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 1.39
Altman-Z N/A
F-Score6
WACC9.36%
ROIC/WACC0.39
Cap/Depr(3y)68.52%
Cap/Depr(5y)73.87%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.87%
EPS 3Y-1.09%
EPS 5Y6.89%
EPS Q2Q%63.93%
EPS Next Y29.83%
EPS Next 2Y23.21%
EPS Next 3Y27.3%
EPS Next 5YN/A
Revenue 1Y (TTM)23.42%
Revenue growth 3Y20.55%
Revenue growth 5Y19.54%
Sales Q2Q%16.39%
Revenue Next Year8.74%
Revenue Next 2Y7.94%
Revenue Next 3Y9.9%
Revenue Next 5YN/A
EBIT growth 1Y186.09%
EBIT growth 3Y8.81%
EBIT growth 5Y48.06%
EBIT Next Year47.4%
EBIT Next 3Y24.63%
EBIT Next 5YN/A
FCF growth 1Y-3.09%
FCF growth 3Y24.87%
FCF growth 5Y4.23%
OCF growth 1Y16.1%
OCF growth 3Y15.31%
OCF growth 5Y16.34%